You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Erlotinib

Showing 26 - 50 of 1,027
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Non-Small Cell Lung
  • Tucson, Arizona
  • +29 more
Aug 18, 2022

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric

Completed
Has Results
  • Unresectable Adenocarcinoma of the Esophagus
  • +3 more
  • Los Angeles, California
  • +1 more
Sep 3, 2021

Esophageal Cancer Trial in United States (Erlotinib, Bevacizumab, Paclitaxel)

Completed
Has Results
  • Esophageal Cancer
  • Erlotinib
  • +6 more
  • Fort Myers, Florida
  • +8 more
Feb 18, 2022

NSCLC Trial in United States (XL647)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Gilroy, California
  • +9 more
May 9, 2022

Lung Cancer Trial in Worldwide (Erlotinib, Bevacizumab)

Completed
Has Results
  • Lung Cancer
  • Caen, France
  • +47 more
Aug 23, 2022

NSCLC Trial in Seoul (CS-7017, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Seoul, Songpa-Gu, Korea, Republic of
    Asan Medical Center
Apr 16, 2021

NSCLC, Brain Cancer Trial in Tucson, Houston (Tarceva (Erlotinib HCl), Radiation Therapy)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Brain Cancer
  • Tarceva (Erlotinib hydrochloride)
  • Radiation Therapy
  • Tucson, Arizona
  • +1 more
Sep 14, 2021

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

Recruiting
  • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2023

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • Erlotinib
  • +3 more
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

c-MET Expression and EGFR Gene Mutation Correlation With

Completed
  • Non-small Cell Lung Cancer Metastatic
  • Non-small Cell Lung Cancer Recurrent
    • Hwasun, Korea, Republic of
      Chonnam National University Hwasun Hospital
    Aug 1, 2021

    Pancreatic Cancer Trial in La Jolla (Gemcitabine, Erlotinib)

    Completed
    • Pancreatic Cancer
    • La Jolla, California
      UCSD Moores Cancer Center
    Mar 1, 2021

    Cancer Trial in Oslo, Trondheim (Erlotinib, Radiation)

    Terminated
    • Cancer
    • Erlotinib
    • Radiation
    • Oslo, International/Other, Norway
    • +1 more
    Mar 25, 2021

    Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Sacramento (Afatinib Dimaleate,

    Completed
    • Recurrent Non-Small Cell Lung Carcinoma
    • +3 more
    • Afatinib Dimaleate
    • Pembrolizumab
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Sep 29, 2021

    Pancreatic Cancer Trial in Loma Linda (Proton, Gemcitabine, Erlotinib, Capecitabine, Proton Radiation)

    Terminated
    Has Results
    • Pancreatic Cancer
    • Proton, Gemcitabine, Erlotinib, Capecitabine
    • Proton Radiation
    • Loma Linda, California
      Loma Linda University Medical Center
    Aug 7, 2021

    Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer Trial in Sarasota, Oklahoma City, Nashville (entinostat,

    Completed
    • Lung Cancer
    • +3 more
    • Sarasota, Florida
    • +2 more
    Nov 11, 2021

    Lung Cancer, Metastatic Cancer Trial in Dallas (Erlotinib plus Romidepsin (8 mg/m^2), Erlotinib plus Romidepsin (10 mg/m^2),

    Completed
    Has Results
    • Lung Cancer
    • Metastatic Cancer
    • Erlotinib plus Romidepsin (8 mg/m^2)
    • +3 more
    • Dallas, Texas
      Simmons Comprehensive Cancer Center at University of Texas South
    Jan 18, 2021

    Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Completed
    Has Results
    • Non-small Cell Lung Carcinoma
    • Pembrolizumab
    • +7 more
    • (no location specified)
    Oct 13, 2022

    NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Pancreatic Cancer Trial in Detroit, Houston (genistein, erlotinib HCl, gemcitabine HCl)

    Completed
    Has Results
    • Pancreatic Cancer
    • genistein
    • +2 more
    • Detroit, Michigan
    • +1 more
    Feb 25, 2021

    Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

    Recruiting
    • Rare Tumor
    • Refractory Tumor
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Feb 16, 2022

    NSCLC Trial in Badalona, Málaga (Docetaxel, Cisplatin, Gemcitabine)

    Completed
    • Non-small Cell Lung Cancer
    • Badalona, Barcelona, Spain
    • +1 more
    Jun 8, 2022

    NSCLC Trial (Gilotrif)

    Completed
    • Non-small Cell Lung Cancer
    • (no location specified)
    Mar 18, 2021

    NSCLC Trial in Canada, United States (Nivolumab, Gemcitabine, Cisplatin)

    Completed
    Has Results
    • Non-small Cell Lung Cancer
    • Nivolumab
    • +8 more
    • Los Angeles, California
    • +11 more
    Sep 20, 2021

    Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

    Recruiting
    • Cancer
    • +3 more
    • Aalborg, Denmark
    • +6 more
    Oct 25, 2022